Neurologic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Phase 3 Trial of Epilepsy Drug for Cognitive Impairment To Be Initiated

Impax Approved for Generic Lamictal ODT

Insulin Nasal Spray May Improve Memory in Alzheimer's Dementia

FDA Wants to Know How Drugs Affect Driving

Cinnamon has shown promise in helping diabetes patients with blood glucose control and in treatment of polycystic ovary syndrome (PCOS), and now the spice could one day benefit patients with multiple sclerosis (MS).

Looking for a Job?

Access our job board to view over 1,400 job openings throughout the US.

New Data on Qudexy XR

Upsher-Smith announced the results of a year-long, open-label extension study of the safety and efficacy of Qudexy XR (topiramate) extended-release capsules as adjunctive therapy in patients with refractory partial-onset seizures (POS).

People with Dementia Often Not Screened

More than half of Americans with dementia have never undergone screening of their cognitive function.

Parkinson's Meds May Spur Compulsive Behaviors

Medications commonly used to treat Parkinson's disease may raise the risk of impulse control disorders such as compulsive gambling, compulsive shopping, and/or hypersexuality.

No Link Between Vaccines, Multiple Sclerosis

There is no link between vaccines and increased risk of multiple sclerosis or other acquired central nervous system demyelinating syndromes, according to a recent study.